Pulmonary hypertension is a life-threatening chronic disorder of the pulmonary circulation. Elevated pressure and resistance in the pulmonary vessels lead to progressive right heart failure which results in functional limitations and ultimately the death of most patients. Thus, the monitoring of right ventricular (RV) function is of great importance. Cardiac magnetic resonance imaging (cardiac MRI) has several advantages over other imaging methods. The use of cine acquisition techniques allows precise description of characteristic volumetric and functional variables, such as right ventricular volumes, muscle mass, stroke volume, ejection fraction, or cardiac output. Impaired right ventricular contractility and function have also been assessed using measures like ventricular septal bowing and pressure-volume loops. MRI investigations have been performed to monitor medical treatment, and the improvement in well-established prognostic factors, such as the 6-min walk, were correlated with measures of right ventricular function. Flow-derived parameters of the pulmonary arteries (such as peak velocity, acceleration time and volume, or pulmonary flow profile) are available using velocity-encoded imaging, and may detect early signs of remodelling. Additionally, magnetic resonance angiography is a promising new tool to visualise pulmonary perfusion and to diagnose chronic thromboembolic pulmonary hypertension. The purpose of this review is to summarise recent advances of cardiovascular magnetic resonance imaging, which will play an increasing role in the comprehensive diagnostic work-up of patients with pulmonary hypertension as a tool to monitor the course of the disease and to evaluate new therapeutic approaches.

Keywords:
Pulmonary hypertension, Cardiovascular magnetic resonance imaging, Right ventricle
1.
Rubin LJ, Badesch DB: Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med 2005;143:282–292.
2.
Peacock AJ: Primary pulmonary hypertension. Thorax 1999;54:1107–1118.
3.
Olschewski H, Rose F, Grunig E, Ghofrani HA, Walmrath D, Schulz R, Schermuly R, Grimminger F, Seeger W: Cellular pathophysiology and therapy of pulmonary hypertension. J Lab Clin Med 2001;138:367–377.
4.
Olschewski H, Olschewski A, Rose F, Schermuly R, Schutte H, Weissmann N, Seeger W, Grimminger F: Physiologic basis for the treatment of pulmonary hypertension. J Lab Clin Med 2001;138:287–297.
5.
Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S: Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(12 suppl):40S–47S.
6.
Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J: Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243–2278.
7.
Olschewski H, Hoeper MM, Borst MM, Ewert R, Grunig E, Kleber FX, Kopp B, Opitz C, Reichenberger F, Schmeisser A, Schranz D, Schulze-Neick I, Wilkens H, Winkler J, Worth H: [Diagnosis and therapy of chronic pulmonary hypertension]. Pneumologie 2006;60:749–771.
8.
D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al: Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343–349.
9.
Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G: Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40:780–788.
10.
Watzinger N, Maier R, Reiter U, Reiter G, Fuernau G, Wonisch M, Fruhwald FM, Schumacher M, Zweiker R, Rienmueller R, Klein W: Clinical applications of cardiovascular magnetic resonance. Curr Pharm Des 2005;11:457–475.
11.
Pujadas S, Reddy GP, Weber O, Lee JJ, Higgins CB: MR imaging assessment of cardiac function. J Magn Reson Imaging 2004;19:789–799.
12.
Pons-Llado G: Assessment of cardiac function by CMR. Eur Radiol 2005;15(suppl 2):B23–B32.
13.
Kosiborod M, Wackers FJ: Assessment of right ventricular morphology and function. Semin Respir Crit Care Med 2003;24:245–262.
14.
Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK: Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson 2004;6:727–765.
15.
Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM: Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735–740.
16.
Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Schwartz T, Koch G, Clayton LM, Jobsis MM, Crow JW, Long W: Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002;39:1214–1219.
17.
Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, Chamera E, Corretti MC, Champion HC, Abraham TP, Girgis RE, Hassoun PM: Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174:1034–1041.
18.
Vitarelli A, Conde Y, Cimino E, Stellato S, D’Orazio S, D’Angeli I, Nguyen BL, Padella V, Caranci F, Petroianni A, D’Antoni L, Terzano C: Assessment of right ventricular function by strain rate imaging in chronic obstructive pulmonary disease. Eur Respir J 2006;27:268–275.
19.
Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB: New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function – a study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357–366.
20.
Rienmuller R: 25 years of cardiac CT imaging: past, present, and future. Herz 2003;28:99–105.
21.
Smit HJ, Vonk-Noordegraaf A, Boonstra A, de Vries PM, Postmus PE: Assessment of the pulmonary volume pulse in idiopathic pulmonary arterial hypertension by means of electrical impedance tomography. Respiration 2006;73:597–602.
22.
Contractor S, Maldjian PD, Sharma VK, Gor DM: Role of helical CT in detecting right ventricular dysfunction secondary to acute pulmonary embolism. J Comput Assist Tomogr 2002;26:587–591.
23.
Lembcke A, Dohmen PM, Dewey M, Klessen C, Elgeti T, Hermann KG, Konertz WF, Hamm B, Kivelitz DE: Multislice computed tomography for preoperative evaluation of right ventricular volumes and function: comparison with magnetic resonance imaging. Ann Thorac Surg 2005;79:1344–1351.
24.
Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ: Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 2004;110:3276–3280.
25.
Muller HM, Tripolt MB, Rehak PH, Groell R, Rienmuller R, Tscheliessnigg KH: Noninvasive measurement of pulmonary vascular resistances by assessment of cardiac output and pulmonary transit time. Invest Radiol 2000;35:727–731.
26.
Bustamante-Labarta M, Perrone S, De La Fuente RL, Stutzbach P, De La Hoz RP, Torino A, Favaloro R: Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. J Am Soc Echocardiogr 2002;15:1160–1164.
27.
Roeleveld RJ, Vonk-Noordegraaf A, Marcus JT, Bronzwaer JG, Marques KM, Postmus PE, Boonstra A: Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest 2004;125:572–579.
28.
Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90:29–34.
29.
Chatzimavroudis GP, Oshinski JN, Franch RH, Walker PG, Yoganathan AP, Pettigrew RI: Evaluation of the precision of magnetic resonance phase velocity mapping for blood flow measurements. J Cardiovasc Magn Reson 2001;3:11–19.
30.
Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ: Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004;147:218–223.
31.
Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU: Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003;17:323–329.
32.
Rominger MB, Bachmann GF, Pabst W, Rau WS: Right ventricular volumes and ejection fraction with fast cine MR imaging in breath-hold technique: applicability, normal values from 52 volunteers, and evaluation of 325 adult cardiac patients. J Magn Reson Imaging 1999;10:908–918.
33.
Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr: Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7–21.
34.
Sandstede J, Lipke C, Beer M, Hofmann S, Pabst T, Kenn W, Neubauer S, Hahn D: Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 2000;10:438–442.
35.
Maceira AM, Prasad SK, Khan M, Pennell DJ: Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J 2006;27:2879–2888.
36.
Raman SV, Shah M, McCarthy B, Garcia A, Ferketich AK: Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance. Am Heart J 2006;151:736–744.
37.
Ahmed S, Shellock FG: Magnetic resonance imaging safety: implications for cardiovascular patients. J Cardiovasc Magn Reson 2001;3:171–182.
38.
Prasad SK, Pennell DJ: Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices. Heart 2004;90:1241–1244.
39.
Plathow C, Ley S, Zaporozhan J, Schobinger M, Gruenig E, Puderbach M, Eichinger M, Meinzer HP, Zuna I, Kauczor HU: Assessment of reproducibility and stability of different breath-hold maneuvres by dynamic MRI: comparison between healthy adults and patients with pulmonary hypertension. Eur Radiol 2006;16:173–179.
40.
Markiewicz W, Sechtem U, Higgins CB: Evaluation of the right ventricle by magnetic resonance imaging. Am Heart J 1987;113:8–15.
41.
Jauhiainen T, Jarvinen VM, Hekali PE: Evaluation of methods for MR imaging of human right ventricular heart volumes and mass. Acta Radiol 2002;43:587–592.
42.
Reiter G, Reiter U, Rienmuller R, Gagarina N, Ryabikin A: On the value of geometry-based models for left ventricular volumetry in magnetic resonance imaging and electron beam tomography: a Bland-Altman analysis. Eur J Radiol 2004;52:110–118.
43.
Marcus JT, Vonk Noordegraaf A, Roeleveld RJ, Postmus PE, Heethaar RM, Van Rossum AC, Boonstra A: Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI. Chest 2001;119:1761–1765.
44.
Hoeper MM, Tongers J, Leppert A, Baus S, Maier R, Lotz J: Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension. Chest 2001;120:502–507.
45.
van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A: Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28:1250–1257.
46.
Torbicki A: Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction. Eur Heart J 2007;28:1187–1189.
47.
Saba TS, Foster J, Cockburn M, Cowan M, Peacock AJ: Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 2002;20:1519–1524.
48.
Holman ER, van Jonbergen HP, van Dijkman PR, van der Laarse A, de Roos A, van der Wall EE: Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardiol 1993;71:1036–1040.
49.
Laissy JP, Messin B, Varenne O, Iung B, Karila-Cohen D, Schouman-Claeys E, Steg PG: MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest 2002;122:1638–1648.
50.
Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, Abe Y, Yamashina A: Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 2004;22:155–161.
51.
Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, Peacock AJ: Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005;26:1993–1999.
52.
Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ: The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260–2264.
53.
Roeleveld RJ, Marcus JT, Faes TJ, Gan TJ, Boonstra A, Postmus PE, Vonk-Noordegraaf A: Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 2005;234:710–717.
54.
Dellegrottaglie S, Sanz J, Poon M, Viles-Gonzalez JF, Sulica R, Goyenechea M, Macaluso F, Fuster V, Rajagopalan S: Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 2007;243:63–69.
55.
Nayler GL, Firmin DN, Longmore DB: Blood flow imaging by cine magnetic resonance. J Comput Assist Tomogr 1986;10:715–722.
56.
Kreitner KF, Ley S, Kauczor HU, Mayer E, Kramm T, Pitton MB, Krummenauer F, Thelen M: Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 2004;232:535–543.
57.
Kuehne T, Yilmaz S, Steendijk P, Moore P, Groenink M, Saaed M, Weber O, Higgins CB, Ewert P, Fleck E, Nagel E, Schulze-Neick I, Lange P: Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 2004;110:2010–2016.
58.
Akbari H RG, Higgins CB: Blood flow measurements; in Higgins CB, de Roos A (eds): Cardiovascular MRI and MRA. Philadelphia, Lippincott Williams & Wilkins, 2003, pp 51–69.
59.
Naeije R, Torbicki A: More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J 1995;8:1445–1449.
60.
Hardziyenka M, Reesink HJ, Bouma BJ, de Bruin-Bon HA, Campian ME, Tanck MW, van den Brink RB, Kloek JJ, Tan HL, Bresser P: A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. Eur Heart J 2007;28:842–849.
61.
Naeije R, Huez S: Reflections on wave reflections in chronic thromboembolic pulmonary hypertension. Eur Heart J 2007;28:785–787.
62.
Razavi R, Hill DL, Keevil SF, Miquel ME, Muthurangu V, Hegde S, Rhode K, Barnett M, van Vaals J, Hawkes DJ, Baker E: Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet 2003;362:1877–1882.
63.
Muthurangu V, Taylor A, Andriantsimiavona R, Hegde S, Miquel ME, Tulloh R, Baker E, Hill DL, Razavi RS: Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase-contrast magnetic resonance flow. Circulation 2004;110:826–834.
64.
Muthurangu V, Atkinson D, Sermesant M, Miquel ME, Hegde S, Johnson R, Andriantsimiavona R, Taylor AM, Baker E, Tulloh R, Hill D, Razavi RS: Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization. Am J Physiol Heart Circ Physiol 2005;289:H1301–H1306.
65.
Kuehne T, Yilmaz S, Schulze-Neick I, Wellnhofer E, Ewert P, Nagel E, Lange P: Magnetic resonance imaging guided catheterisation for assessment of pulmonary vascular resistance: in vivo validation and clinical application in patients with pulmonary hypertension. Heart 2005;91:1064–1069.
66.
Kondo C, Caputo GR, Masui T, Foster E, O’Sullivan M, Stulbarg MS, Golden J, Catterjee K, Higgins CB: Pulmonary hypertension: pulmonary flow quantification and flow profile analysis with velocity-encoded cine MR imaging. Radiology 1992;183:751–758.
67.
Tardivon AA, Mousseaux E, Brenot F, Bittoun J, Jolivet O, Bourroul E, Duroux P: Quantification of hemodynamics in primary pulmonary hypertension with magnetic resonance imaging. Am J Respir Crit Care Med 1994;150:1075–1080.
68.
Roeleveld RJ, Marcus JT, Boonstra A, Postmus PE, Marques KM, Bronzwaer JG, Vonk-Noordegraaf A: A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005;22:67–72.
69.
Mousseaux E, Tasu JP, Jolivet O, Simonneau G, Bittoun J, Gaux JC: Pulmonary arterial resistance: noninvasive measurement with indexes of pulmonary flow estimated at velocity-encoded MR imaging – preliminary experience. Radiology 1999;212:896–902.
70.
Bouchard A, Higgins CB, Byrd BF, 3rd, Amparo EG, Osaki L, Axelrod R: Magnetic resonance imaging in pulmonary arterial hypertension. Am J Cardiol 1985;56:938–942.
71.
von Schulthess GK, Fisher MR, Higgins CB: Pathologic blood flow in pulmonary vascular disease as shown by gated magnetic resonance imaging. Ann Intern Med 1985;103:317–323.
72.
Bogren HG, Klipstein RH, Mohiaddin RH, Firmin DN, Underwood SR, Rees RS, Longmore DB: Pulmonary artery distensibility and blood flow patterns: a magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension. Am Heart J 1989;118:990–999.
73.
Sanz J, Kuschnir P, Rius T, Salguero R, Sulica R, Einstein AJ, Dellegrottaglie S, Fuster V, Rajagopalan S, Poon M: Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007;243:70–79.
74.
Laffon E, Laurent F, Bernard V, De Boucaud L, Ducassou D, Marthan R: Noninvasive assessment of pulmonary arterial hypertension by MR phase-mapping method. J Appl Physiol 2001;90:2197–2202.
75.
Laffon E, Vallet C, Bernard V, Montaudon M, Ducassou D, Laurent F, Marthan R: A computed method for noninvasive MRI assessment of pulmonary arterial hypertension. J Appl Physiol 2004;96:463–468.
76.
Lankhaar JW, Vonk Noordegraaf A, Marcus JT: A computed method for noninvasive MRI assessment of pulmonary arterial hypertension. J Appl Physiol 2004;97:794; author reply 794–795.
77.
Ley S, Puderbach M, Fink C, Eichinger M, Plathow C, Teiner S, Wiebel M, Muller FM, Kauczor HU: Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI. Eur Radiol 2005;15:1575–1580.
78.
Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257–2264.
79.
Seyfarth HJ, Hammerschmidt S, Pankau H, Winkler J, Wirtz H: Long-term bosentan in chronic thromboembolic pulmonary hypertension. Respiration 2007;74:287–292.
80.
Krug S, Hammerschmidt S, Pankau H, Wirtz H, Seyfarth HJ: Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension. Respiration 2008;76:154–159.
81.
Fedullo PF, Auger WR, Kerr KM, Rubin LJ: Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465–1472.
82.
Frazier AA, Galvin JR, Franks TJ, Rosado-De-Christenson ML: From the archives of the AFIP: pulmonary vasculature: hypertension and infarction. Radiographics 2000;20:491–524; quiz 530–531, 532.
83.
Rubin L: Chronic thromboembolic hypertension. N Engl J Med 2002;346:866.
84.
McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, Loyd JE: Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126(suppl 1):14S–34S.
85.
Olschewski H: [Current recommendations for the diagnosis and treatment of pulmonary hypertension]. Dtsch Med Wochenschr 2006;131(suppl 9):S334–S337.
86.
Garg K, Macey L: Helical CT scanning in the diagnosis of pulmonary embolism. Respiration 2003;70:231–237.
87.
Ohno Y, Hatabu H, Murase K, Higashino T, Kawamitsu H, Watanabe H, Takenaka D, Fujii M, Sugimura K: Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: Preliminary experience in 40 subjects. J Magn Reson Imaging 2004;20:353–365.
88.
Ley S, Fink C, Zaporozhan J, Borst MM, Meyer FJ, Puderbach M, Eichinger M, Plathow C, Grunig E, Kreitner KF, Kauczor HU: Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results. Eur Radiol 2005;15:2256–2263.
89.
Kauczor HU, Schwickert HC, Mayer E, Schweden F, Schild HH, Thelen M: Spiral CT of bronchial arteries in chronic thromboembolism. J Comput Assist Tomogr 1994;18:855–861.
90.
Ley S, Kauczor HU, Heussel CP, Kramm T, Mayer E, Thelen M, Kreitner KF: Value of contrast-enhanced MR angiography and helical CT angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 2003;13:2365–2371.
91.
Kreitner KF, Ley S, Kauczor HU, Kalden P, Pitton MB, Mayer E, Laub G, Thelen M: [Contrast media enhanced three dimensional MR angiography of the pulmonary arteries in patients with chronic recurrent pulmonary embolism – comparison with selective intra-arterial DSA]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2000;172:122–128.
92.
Ley S, Kreitner KF, Morgenstern I, Thelen M, Kauczor HU: Bronchopulmonary shunts in patients with chronic thromboembolic pulmonary hypertension: evaluation with helical CT and MR imaging. AJR Am J Roentgenol 2002;179:1209–1215.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.